Study of the potential reversal of triazolam memory and cognitive deficits by RU 41 656 in healthy subjects

A double-blind, placebo-controlled study

A double-blind, placebo-controlled study of the effects of eptastigmine on scopolamine-induced cognitive deficits in healthy male subjects

✍ C. R. Lines; J. H. Ambrose; A. Heald; M. Traub 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 612 KB

This double-blind, placebo-controlled, crossover study examined the effects of two single doses of eptastigmine, a novel cholinesterase inhibitor, on scopolamine-induced cognitive deficits in 24 healthy male volunteers. Each subject received the following treatment sequences, separated by at least 1